Go Pro

VectivBio (VECT) Competitors

VectivBio logo
$16.85 0.00 (0.00%)
As of 09/4/2026

VECT vs. ALVOW, APLMW, ARAV, BIAFW, and BIVIW

Should you buy VectivBio stock or one of its competitors? VectivBio's main competitors and comparable companies include Alvotech (ALVOW), Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), and BioVie (BIVIW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does VectivBio compare to Alvotech?

Alvotech (NASDAQ:ALVOW) and VectivBio (NASDAQ:VECT) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
VectivBioN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
VectivBio N/A N/A N/A

In the previous week, Alvotech had 1 more articles in the media than VectivBio. MarketBeat recorded 1 mentions for Alvotech and 0 mentions for VectivBio. Alvotech's average media sentiment score of 0.92 beat VectivBio's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
VectivBio Neutral

Summary

Alvotech beats VectivBio on 3 of the 3 factors compared between the two stocks.

How does VectivBio compare to Apollomics?

Apollomics (NASDAQ:APLMW) and VectivBio (NASDAQ:VECT) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, risk, profitability, earnings, institutional ownership, valuation, media sentiment and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
VectivBioN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
VectivBio N/A N/A N/A

In the previous week, Apollomics' average media sentiment score of 0.00 equaled VectivBio'saverage media sentiment score.

Company Overall Sentiment
Apollomics Neutral
VectivBio Neutral

Summary

Apollomics beats VectivBio on 1 of the 1 factors compared between the two stocks.

How does VectivBio compare to Aravive?

VectivBio (NASDAQ:VECT) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, analyst recommendations, risk, valuation, institutional ownership, media sentiment, profitability and dividends.

35.8% of Aravive shares are held by institutional investors. 9.7% of VectivBio shares are held by insiders. Comparatively, 60.4% of Aravive shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, VectivBio's average media sentiment score of 0.00 equaled Aravive'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
Aravive Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
Aravive N/A N/A N/A

Summary

Aravive beats VectivBio on 2 of the 2 factors compared between the two stocks.

How does VectivBio compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and VectivBio (NASDAQ:VECT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends, media sentiment and valuation.

In the previous week, bioAffinity Technologies had 2 more articles in the media than VectivBio. MarketBeat recorded 2 mentions for bioAffinity Technologies and 0 mentions for VectivBio. VectivBio's average media sentiment score of 0.00 beat bioAffinity Technologies' score of -0.66 indicating that VectivBio is being referred to more favorably in the news media.

Company Overall Sentiment
bioAffinity Technologies Negative
VectivBio Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
VectivBioN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
VectivBio N/A N/A N/A

Summary

bioAffinity Technologies beats VectivBio on 2 of the 3 factors compared between the two stocks.

How does VectivBio compare to BioVie?

VectivBio (NASDAQ:VECT) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, profitability, dividends, analyst recommendations, risk, media sentiment and institutional ownership.

In the previous week, BioVie had 1 more articles in the media than VectivBio. MarketBeat recorded 1 mentions for BioVie and 0 mentions for VectivBio. VectivBio's average media sentiment score of 0.00 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
VectivBio Neutral
BioVie Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VectivBioN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
VectivBioN/A N/A N/A
BioVie N/A N/A N/A

Summary

BioVie beats VectivBio on 1 of the 1 factors compared between the two stocks.

Get VectivBio News Delivered to You Automatically

Sign up to receive the latest news and ratings for VECT and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding VECT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VECT vs. The Competition

MetricVectivBioBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$4.01B$7.25B$12.91B
Dividend YieldN/A3.60%2.53%9.14%
P/E RatioN/A12.77274.1025.45
Price / SalesN/A1,399.64637.09105.93
Price / CashN/A108.6077.0852.44
Price / BookN/A16.1412.856.17
Net IncomeN/A-$22.80M$3.49B$350.08M
7 Day PerformanceN/A0.31%1.04%-0.14%
1 Month PerformanceN/A7.97%5.39%0.94%
1 Year PerformanceN/A49.26%24.18%14.02%

VectivBio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VECT
VectivBio
N/A$16.85
flat
N/AN/A$0.00N/AN/A30
ALVOW
Alvotech
N/A$0.38
flat
N/A-73.9%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
-0.7%
N/A+0.0%$0.00$8.50MN/A59
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.13
+78.4%
N/A+704.6%$0.00$5.85MN/A10

Related Companies and Tools


This page (NASDAQ:VECT) was last updated on 9/6/2026 by MarketBeat.com Staff.
From Our Partners